Cardiff Oncology (CRDF) Receivables - Net (2011 - 2026)

Cardiff Oncology has reported Receivables - Net for 15 years, with the latest figure at $182000.0 in Q4 2025.

• Quarterly Receivables - Net fell 76.46% year-over-year to $182000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $182000.0 (down 76.46% YoY) and the FY2025 annual result came in at $182000.0, down 76.46% from the prior year.
• Receivables - Net declined to $182000.0 in Q4 2025 per CRDF's latest filing, from $254000.0 in the prior quarter.
• Over five years, Receivables - Net peaked at $773000.0 in Q4 2024 and troughed at $161000.0 in Q2 2023.
• A 5-year average of $441200.0 and a median of $426000.0 in 2022 frame the typical range for Receivables - Net.
• The sharpest annual moves came in 2024 and 2025: Receivables - Net jumped 212.12% in 2024, then plunged 76.46% in 2025.
• Over 5 years, Receivables - Net stood at $535000.0 in 2021, then jumped by 44.11% to $771000.0 in 2022, then tumbled by 62.65% to $288000.0 in 2023, then jumped by 168.4% to $773000.0 in 2024, then slumped by 76.46% to $182000.0 in 2025.
• According to Business Quant data, Receivables - Net over the past three periods registered $182000.0, $254000.0, and $526000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.